InMode Ltd. (NASDAQ:INMD) Given Average Recommendation of "Hold" by Brokerages

Shares of InMode Ltd. (NASDAQ:INMD - Get Free Report) have earned a consensus rating of "Hold" from the six analysts that are presently covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $22.60.

A number of equities research analysts have weighed in on INMD shares. Needham & Company LLC reiterated a "hold" rating on shares of InMode in a research report on Thursday, October 31st. BTIG Research began coverage on shares of InMode in a report on Thursday, October 17th. They issued a "buy" rating and a $25.00 target price for the company. Finally, Barclays cut their target price on InMode from $29.00 to $27.00 and set an "overweight" rating on the stock in a research report on Monday, October 14th.

Institutional Trading of InMode

A number of large investors have recently modified their holdings of INMD. Asset Dedication LLC purchased a new stake in InMode during the 2nd quarter worth about $33,000. nVerses Capital LLC purchased a new stake in shares of InMode during the second quarter worth approximately $42,000. Nisa Investment Advisors LLC raised its holdings in InMode by 314.7% in the third quarter. Nisa Investment Advisors LLC now owns 3,550 shares of the healthcare company's stock valued at $60,000 after acquiring an additional 2,694 shares in the last quarter. Quarry LP lifted its stake in InMode by 154.3% in the third quarter. Quarry LP now owns 3,781 shares of the healthcare company's stock worth $64,000 after acquiring an additional 2,294 shares during the last quarter. Finally, National Bank of Canada FI grew its holdings in InMode by 40.7% during the 2nd quarter. National Bank of Canada FI now owns 9,406 shares of the healthcare company's stock worth $168,000 after acquiring an additional 2,720 shares in the last quarter. Hedge funds and other institutional investors own 68.04% of the company's stock.

InMode Price Performance

Shares of NASDAQ:INMD traded up $0.05 during midday trading on Friday, reaching $17.01. 565,583 shares of the company's stock were exchanged, compared to its average volume of 556,042. The stock has a market cap of $1.43 billion, a price-to-earnings ratio of 9.19 and a beta of 2.12. InMode has a fifty-two week low of $14.87 and a fifty-two week high of $26.80. The firm's 50 day simple moving average is $18.17 and its two-hundred day simple moving average is $17.35.

InMode Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.